Quantum Genomics Corp. Widens Net with Acquisition of Eurobiobiz SAS

JERSEY CITY, N.J. - October 29, 2007 - Quantum Genomics Corp. (QGC), a global biotech company developing new drugs for metabolic and cardiovascular diseases, announces today the acquisition of Eurobiobiz SAS, a company specializing in the identification and development of high value-added projects in the field of life sciences and academic research. Financial terms were not disclosed.

Back to news